{"pmid":32500339,"title":"The craniotomy box: an innovative method of containing hazardous aerosols generated during skull saw use in autopsy on a COVID-19 body.","text":["The craniotomy box: an innovative method of containing hazardous aerosols generated during skull saw use in autopsy on a COVID-19 body.","During a disease pandemic, there is still a requirement to perform postmortem examinations within the context of legal considerations. The management of the dead from COVID-19 should not impede the medicolegal investigation of the death where required by the authorities and legislation but additional health and safety precautions should be adopted for the necessary postmortem procedures. The authors have therefore used the craniotomy box in an innovative way to enable a safe alternative for skull and brain removal procedures on suspected or confirmed COVID-19 bodies. The craniotomy box technique was tested on a confirmed COVID-19 positive body where a full postmortem examination was performed by a team of highly trained personnel in a negative pressure Biosafety Level 3 (BSL-3) autopsy suite in the National Institute of Forensic Medicine (IPFN) Malaysia. This craniotomy box is a custom-made transparent plastic box with five walls but without a floor. Two circular holes were made in one wall for the placement of arms in order to perform the skull opening procedure. A swab to detect the presence of the SARS-CoV-2 virus was taken from the interior surface of the craniotomy box after the procedure. The result from the test using real-time reverse transcriptase polymerase chain reaction (rRT-PCR) proved that an additional barrier provided respiratory protection by containing the aerosols generated from the skull opening procedure. This innovation ensures procedures performed inside this craniotomy box are safe for postmortem personnel performing high risk autopsies during pandemics.","Forensic Sci Med Pathol","Hasmi, Ahmad Hafizam","Khoo, Lay See","Koo, Zhao Peng","Suriani, Muhammad Uzair Ahmad","Hamdan, Ain Nurfarahana","Yaro, Siti Wira Md","Arshad, Salmah","Siew, Sheue Feng","Ibrahim, Mohamad Azaini","Mahmood, Mohd Shah","32500339"],"abstract":["During a disease pandemic, there is still a requirement to perform postmortem examinations within the context of legal considerations. The management of the dead from COVID-19 should not impede the medicolegal investigation of the death where required by the authorities and legislation but additional health and safety precautions should be adopted for the necessary postmortem procedures. The authors have therefore used the craniotomy box in an innovative way to enable a safe alternative for skull and brain removal procedures on suspected or confirmed COVID-19 bodies. The craniotomy box technique was tested on a confirmed COVID-19 positive body where a full postmortem examination was performed by a team of highly trained personnel in a negative pressure Biosafety Level 3 (BSL-3) autopsy suite in the National Institute of Forensic Medicine (IPFN) Malaysia. This craniotomy box is a custom-made transparent plastic box with five walls but without a floor. Two circular holes were made in one wall for the placement of arms in order to perform the skull opening procedure. A swab to detect the presence of the SARS-CoV-2 virus was taken from the interior surface of the craniotomy box after the procedure. The result from the test using real-time reverse transcriptase polymerase chain reaction (rRT-PCR) proved that an additional barrier provided respiratory protection by containing the aerosols generated from the skull opening procedure. This innovation ensures procedures performed inside this craniotomy box are safe for postmortem personnel performing high risk autopsies during pandemics."],"journal":"Forensic Sci Med Pathol","authors":["Hasmi, Ahmad Hafizam","Khoo, Lay See","Koo, Zhao Peng","Suriani, Muhammad Uzair Ahmad","Hamdan, Ain Nurfarahana","Yaro, Siti Wira Md","Arshad, Salmah","Siew, Sheue Feng","Ibrahim, Mohamad Azaini","Mahmood, Mohd Shah"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500339","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s12024-020-00270-z","keywords":["aerosol-generating procedure","autopsy","covid-19","craniotomy box","safe alternative"],"locations":["Malaysia","craniotomy"],"countries":["Malaysia"],"countries_codes":["MYS|Malaysia"],"topics":["Prevention"],"weight":1,"_version_":1668804508727115776,"score":9.490897,"similar":[{"pmid":32357503,"title":"COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!","text":["COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!","The current outbreak of COVID-19 severe respiratory disease, which started in Wuhan, China, is an ongoing challenge, and a major threat to public health that requires surveillance, prompt diagnosis, and research efforts to understand this emergent pathogen and to develop an effective response. Due to the scientific community's efforts, there is an increasing body of published studies describing the virus' biology, its transmission and diagnosis, its clinical features, its radiological findings, and the development of candidate therapeutics and vaccines. Despite the decline in postmortem examination rate, autopsy remains the gold standard to determine why and how death happens. Defining the pathophysiology of death is not only limited to forensic considerations; it may also provide useful clinical and epidemiologic insights. Selective approaches to postmortem diagnosis, such as limited postmortem sampling over full autopsy, can also be useful in the control of disease outbreaks and provide valuable knowledge for managing appropriate control measures. In this scenario, we strongly recommend performing full autopsies on patients who died with suspected or confirmed COVID-19 infection, particularly in the presence of several comorbidities. Only by working with a complete set of histological samples obtained through autopsy can one ascertain the exact cause(s) of death, optimize clinical management, and assist clinicians in pointing out a timely and effective treatment to reduce mortality. Death can teach us not only about the disease, it might also help with its prevention and, above all, treatment.","J Clin Med","Pomara, Cristoforo","Li Volti, Giovanni","Cappello, Francesco","32357503"],"abstract":["The current outbreak of COVID-19 severe respiratory disease, which started in Wuhan, China, is an ongoing challenge, and a major threat to public health that requires surveillance, prompt diagnosis, and research efforts to understand this emergent pathogen and to develop an effective response. Due to the scientific community's efforts, there is an increasing body of published studies describing the virus' biology, its transmission and diagnosis, its clinical features, its radiological findings, and the development of candidate therapeutics and vaccines. Despite the decline in postmortem examination rate, autopsy remains the gold standard to determine why and how death happens. Defining the pathophysiology of death is not only limited to forensic considerations; it may also provide useful clinical and epidemiologic insights. Selective approaches to postmortem diagnosis, such as limited postmortem sampling over full autopsy, can also be useful in the control of disease outbreaks and provide valuable knowledge for managing appropriate control measures. In this scenario, we strongly recommend performing full autopsies on patients who died with suspected or confirmed COVID-19 infection, particularly in the presence of several comorbidities. Only by working with a complete set of histological samples obtained through autopsy can one ascertain the exact cause(s) of death, optimize clinical management, and assist clinicians in pointing out a timely and effective treatment to reduce mortality. Death can teach us not only about the disease, it might also help with its prevention and, above all, treatment."],"journal":"J Clin Med","authors":["Pomara, Cristoforo","Li Volti, Giovanni","Cappello, Francesco"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32357503","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3390/jcm9051259","keywords":["covid-19","autopsy","diagnosis","infectious diseases"],"locations":["Wuhan","China","Autopsy","Autopsy","Autopsy"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1666138495334219776,"score":361.429},{"pmid":32275742,"pmcid":"PMC7184436","title":"COVID-19 Autopsies, Oklahoma, USA.","text":["COVID-19 Autopsies, Oklahoma, USA.","OBJECTIVES: To report the methods and findings of two complete autopsies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive individuals who died in Oklahoma (United States) in March 2020. METHODS: Complete postmortem examinations were performed according to standard procedures in a negative-pressure autopsy suite/isolation room using personal protective equipment, including N95 masks, eye protection, and gowns. The diagnosis of coronavirus disease 2019 (COVID-19) was confirmed by real-time reverse transcriptase polymerase chain reaction testing on postmortem swabs. RESULTS: A 77-year-old obese man with a history of hypertension, splenectomy, and 6 days of fever and chills died while being transported for medical care. He tested positive for SARS-CoV-2 on postmortem nasopharyngeal and lung parenchymal swabs. Autopsy revealed diffuse alveolar damage and chronic inflammation and edema in the bronchial mucosa. A 42-year-old obese man with a history of myotonic dystrophy developed abdominal pain followed by fever, shortness of breath, and cough. Postmortem nasopharyngeal swab was positive for SARS-CoV-2; lung parenchymal swabs were negative. Autopsy showed acute bronchopneumonia with evidence of aspiration. Neither autopsy revealed viral inclusions, mucus plugging in airways, eosinophils, or myocarditis. CONCLUSIONS: SARS-CoV-2 testing can be performed at autopsy. Autopsy findings such as diffuse alveolar damage and airway inflammation reflect true virus-related pathology; other findings represent superimposed or unrelated processes.","Am J Clin Pathol","Barton, Lisa M","Duval, Eric J","Stroberg, Edana","Ghosh, Subha","Mukhopadhyay, Sanjay","32275742"],"abstract":["OBJECTIVES: To report the methods and findings of two complete autopsies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive individuals who died in Oklahoma (United States) in March 2020. METHODS: Complete postmortem examinations were performed according to standard procedures in a negative-pressure autopsy suite/isolation room using personal protective equipment, including N95 masks, eye protection, and gowns. The diagnosis of coronavirus disease 2019 (COVID-19) was confirmed by real-time reverse transcriptase polymerase chain reaction testing on postmortem swabs. RESULTS: A 77-year-old obese man with a history of hypertension, splenectomy, and 6 days of fever and chills died while being transported for medical care. He tested positive for SARS-CoV-2 on postmortem nasopharyngeal and lung parenchymal swabs. Autopsy revealed diffuse alveolar damage and chronic inflammation and edema in the bronchial mucosa. A 42-year-old obese man with a history of myotonic dystrophy developed abdominal pain followed by fever, shortness of breath, and cough. Postmortem nasopharyngeal swab was positive for SARS-CoV-2; lung parenchymal swabs were negative. Autopsy showed acute bronchopneumonia with evidence of aspiration. Neither autopsy revealed viral inclusions, mucus plugging in airways, eosinophils, or myocarditis. CONCLUSIONS: SARS-CoV-2 testing can be performed at autopsy. Autopsy findings such as diffuse alveolar damage and airway inflammation reflect true virus-related pathology; other findings represent superimposed or unrelated processes."],"journal":"Am J Clin Pathol","authors":["Barton, Lisa M","Duval, Eric J","Stroberg, Edana","Ghosh, Subha","Mukhopadhyay, Sanjay"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275742","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1093/ajcp/aqaa062","keywords":["acute lung injury","autopsy","covid-19","coronavirus","diffuse alveolar damage","pulmonary pathology","sars-cov-2"],"locations":["Oklahoma","United States","obese","obese","Oklahoma","USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1666138491676786692,"score":338.76837},{"pmid":32397008,"title":"The aerosol box for intubation in COVID-19 patients: an in-situ simulation crossover study.","text":["The aerosol box for intubation in COVID-19 patients: an in-situ simulation crossover study.","The COVID-19 pandemic has led to the manufacturing of novel devices to protect clinicians from the risk of transmission, including the aerosol box for use in intubation. We evaluated the impact of two aerosol boxes (an early-generation box and a latest-generation box) on intubations in patients with severe COVID-19 with an in-situ simulation crossover study. The simulated process complied with the Safe Airway Society COVID-19 airway management guidelines. The primary outcome was intubation time; secondary outcomes included first-pass success and breaches to personal protective equipment. All intubations were performed by specialist (consultant) anaesthetists and video recorded. Twelve anaesthetists performed 36 intubations. Intubation time with no aerosol box was significantly shorter than with the early-generation box ((median (IQR [range])) 42.9 (32.9-46.9 [30.9-57.6]) seconds vs. 82.1(45.1-98.3 [30.8-180.0]) seconds, p=0.002) and the latest-generation box (52.4(43.1-70.3 [35.7-169.2]) seconds, p=0.008). No intubations without a box took more than one minute, whereas 14 (58%) intubations with a box took over one minute and 4 (17%) took over two minutes (including one failure). Without an aerosol box, all anaesthetists obtained first-pass success. With the early-generation and latest-generation boxes, 9 (75%) and 10 (83%) participants obtained first-pass success respectively. One breach of personal protective equipment occurred using the early-generation box and seven breaches occurred using the latest-generation box. Aerosol boxes may increase intubation times and therefore expose patients to the risk of hypoxia. They may cause damage to conventional personal protective equipment and therefore place clinicians at risk of infection. Further research is required before these devices can be considered safe for clinical use.","Anaesthesia","Begley, J L","Lavery, K E","Nickson, C P","Brewster, D J","32397008"],"abstract":["The COVID-19 pandemic has led to the manufacturing of novel devices to protect clinicians from the risk of transmission, including the aerosol box for use in intubation. We evaluated the impact of two aerosol boxes (an early-generation box and a latest-generation box) on intubations in patients with severe COVID-19 with an in-situ simulation crossover study. The simulated process complied with the Safe Airway Society COVID-19 airway management guidelines. The primary outcome was intubation time; secondary outcomes included first-pass success and breaches to personal protective equipment. All intubations were performed by specialist (consultant) anaesthetists and video recorded. Twelve anaesthetists performed 36 intubations. Intubation time with no aerosol box was significantly shorter than with the early-generation box ((median (IQR [range])) 42.9 (32.9-46.9 [30.9-57.6]) seconds vs. 82.1(45.1-98.3 [30.8-180.0]) seconds, p=0.002) and the latest-generation box (52.4(43.1-70.3 [35.7-169.2]) seconds, p=0.008). No intubations without a box took more than one minute, whereas 14 (58%) intubations with a box took over one minute and 4 (17%) took over two minutes (including one failure). Without an aerosol box, all anaesthetists obtained first-pass success. With the early-generation and latest-generation boxes, 9 (75%) and 10 (83%) participants obtained first-pass success respectively. One breach of personal protective equipment occurred using the early-generation box and seven breaches occurred using the latest-generation box. Aerosol boxes may increase intubation times and therefore expose patients to the risk of hypoxia. They may cause damage to conventional personal protective equipment and therefore place clinicians at risk of infection. Further research is required before these devices can be considered safe for clinical use."],"journal":"Anaesthesia","authors":["Begley, J L","Lavery, K E","Nickson, C P","Brewster, D J"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32397008","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/anae.15115","keywords":["covid-19","ppe","rsi","aerosol box","barrier device","intubation","personal protective equipment","rapid sequence induction"],"locations":["hypoxia"],"topics":["Prevention"],"weight":1,"_version_":1666627828043481088,"score":334.59583},{"pmid":32348556,"title":"Maximising application of the Aerosol Box in protecting healthcare workers during the covid-19 pandemic.","text":["Maximising application of the Aerosol Box in protecting healthcare workers during the covid-19 pandemic.","We report the rapid evolution of the Aerosol Box, originally designed by Dr Hsien Yung Lai, Mennonite Christian Hospital, Taiwan [1]. The Aerosol Box was intended to protect healthcare workers performing aerosol generating procedures (AGPs), specifically tracheal intubation, by providing a physical barrier to droplet and/or aerosol exposure [2]. An increased infection rate has been reported in healthcare workers internationally, particularly when the level of personal protective equipment (PPE) has been inadequate or when the supply of PPE has been depleted [3]. The Aerosol Box can be made of transparent acrylic or polycarbonate sheeting, and is re-usable after careful decontamination with an appropriate cleansing agent. The original model was based on a simple cuboid design, with two access ports for arms.","Anaesthesia","Malik, J S","Jenner, C","Ward, P A","32348556"],"abstract":["We report the rapid evolution of the Aerosol Box, originally designed by Dr Hsien Yung Lai, Mennonite Christian Hospital, Taiwan [1]. The Aerosol Box was intended to protect healthcare workers performing aerosol generating procedures (AGPs), specifically tracheal intubation, by providing a physical barrier to droplet and/or aerosol exposure [2]. An increased infection rate has been reported in healthcare workers internationally, particularly when the level of personal protective equipment (PPE) has been inadequate or when the supply of PPE has been depleted [3]. The Aerosol Box can be made of transparent acrylic or polycarbonate sheeting, and is re-usable after careful decontamination with an appropriate cleansing agent. The original model was based on a simple cuboid design, with two access ports for arms."],"journal":"Anaesthesia","authors":["Malik, J S","Jenner, C","Ward, P A"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348556","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/anae.15109","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138495452708864,"score":333.66605},{"pmid":32383963,"title":"SARS-CoV-2 Pandemic: Review of the Literature and Proposal for Safe Autopsy Practice.","text":["SARS-CoV-2 Pandemic: Review of the Literature and Proposal for Safe Autopsy Practice.","Context: The novel coronavirus disease 2019 (COVID-19) pandemic is significantly changing methodological approaches in all branches of the health system. From a forensic point of view, this event is partly changing the manner in which forensic pathologists and all those who work in autopsy services operate, but above all, it is changing the patterns established for years by which cadavers were analysed postmortem. Objective: To present a review of the literature and a proposal for COVID autopsy protocols. To contain the infection risk, a revision of all the protocols that until now have been applied to the examination of bodies that require autopsy services is required. Data source: Currently, the diagnosis and postmortem analysis of positive or suspected COVID-19 cases plays a crucial role in scientific research. A review of the main recommendations proposed by international scientific societies regarding the risk of infection during autopsy has been carried out. Scientific papers currently available via the PubMed NCBI search engine on COVID-19 postmortem diagnosis were also examined. Discussion: Throughout the history of medicine, the role of autopsy has been fundamental to the understanding of multiple pathogenic processes that are investigated postmortem through autopsy. The purpose of the study is to propose an operating protocol that can be useful for all clinical and forensic autopsies with particular reference to the correct methods to be applied to the examination of positive or suspected COVID-19 cases regarding both the autopsy procedure and the collection and analysis of biological samples.","Arch Pathol Lab Med","Aquila, Isabella","Sacco, Matteo Antonio","Abenavoli, Ludovico","Malara, Natalia","Arena, Vincenzo","Grassi, Simone","Ausania, Francesco","Boccuto, Luigi","Ricci, Cristoforo","Gratteri, Santo","Oliva, Antonio","Ricci, Pietrantonio","32383963"],"abstract":["Context: The novel coronavirus disease 2019 (COVID-19) pandemic is significantly changing methodological approaches in all branches of the health system. From a forensic point of view, this event is partly changing the manner in which forensic pathologists and all those who work in autopsy services operate, but above all, it is changing the patterns established for years by which cadavers were analysed postmortem. Objective: To present a review of the literature and a proposal for COVID autopsy protocols. To contain the infection risk, a revision of all the protocols that until now have been applied to the examination of bodies that require autopsy services is required. Data source: Currently, the diagnosis and postmortem analysis of positive or suspected COVID-19 cases plays a crucial role in scientific research. A review of the main recommendations proposed by international scientific societies regarding the risk of infection during autopsy has been carried out. Scientific papers currently available via the PubMed NCBI search engine on COVID-19 postmortem diagnosis were also examined. Discussion: Throughout the history of medicine, the role of autopsy has been fundamental to the understanding of multiple pathogenic processes that are investigated postmortem through autopsy. The purpose of the study is to propose an operating protocol that can be useful for all clinical and forensic autopsies with particular reference to the correct methods to be applied to the examination of positive or suspected COVID-19 cases regarding both the autopsy procedure and the collection and analysis of biological samples."],"journal":"Arch Pathol Lab Med","authors":["Aquila, Isabella","Sacco, Matteo Antonio","Abenavoli, Ludovico","Malara, Natalia","Arena, Vincenzo","Grassi, Simone","Ausania, Francesco","Boccuto, Luigi","Ricci, Cristoforo","Gratteri, Santo","Oliva, Antonio","Ricci, Pietrantonio"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32383963","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.5858/arpa.2020-0165-SA","topics":["Prevention"],"weight":1,"_version_":1666419683215015938,"score":323.66678}]}